Home / Import refusals / AEK-9383848-8/130003/1

FDA Import Refusal AEK-9383848-8/130003/1 — Macleods Pharmaceuticals

Macleods Pharmaceuticals — FEI 3012367935

The FDA refused shipment AEK-9383848-8/130003/1 from Macleods Pharmaceuticals (India) on February 20, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 20, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PDY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118,75

Other import refusals

  • 1FX-0103353-9/10002/1 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0593779-1/10002/7 (Tue May 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4442733-1/10003/1 (Wed Apr 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9395496-2/40003/1 (Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9274982-7/40003/1 (Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources